LIVE MARKET TRACKER :   BSE SENSEX   26085.53      |    NSE NIFTY 7783.35    
GLOBAL MARKETS :  NASDAQ 4462.902   +0.45%    |    FSI London 6773.44   -0.50%    |    NIKKEI Japan 15686.33   +0.26%
  USD GBP EUR CAD AUD INR
USD - 0.5909 0.7465 1.0905 1.0735 60.244
GBP 1.6928 - 1.2636 1.8459 1.8173 101.981
EUR 1.3397 0.7917 - 1.4609 1.4382 80.7095
CAD 0.9171 0.5419 0.6846 - 0.9846 55.2505
AUD 0.9317 0.5506 0.6955 1.016 - 56.1311
INR 0.0166 0.0098 0.0124 0.0181 0.0178 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
Retail Inflation eases to 29-month low at 7.31% in June; Core inflation softens too
(15-Jul-2014)

Retail Inflation eases to 29-month low at 7.31% in June; Core inflation softens tooIn yet another encouraging development after four month low headline inflation numbers, provisional annual inflation rate based on all India general Consumer Price Index (CPI) (Combined) softened to 29......click on news to read complete article.

Tata Motors, Infosys and Suzlon to see some action today
(11-Jul-2014)

Tata Motors, Infosys and Suzlon to see some action todayTata Motors-owned luxury car maker Jaguar Land Rover (JLR) has registered its strongest ever half-year sales in 2014 selling over 240,000 vehicles. The UK-based auto major sold 240,372 cars between January......click on news to read complete article.

Railway Budget 2014-15 to be "growth oriented", big ticket announcements eyed
(08-Jul-2014)

Railway Budget 2014-15 to be "growth oriented", big ticket announcements eyedHaving done a pre-Budget hike of 14.2% in passenger fares and raising freight rates, Railway Minister Sadananda Gowda's will present his maiden Rail Budget amidst expectation of big ticket announcements,......click on news to read complete article.

International Stock News
US markets closed mostly up; Dow ends in red
(31-Jul-2014)

US markets closed mostly up; Dow ends in redThe US markets finished a choppy session mixed on Wednesday, as the Federal Reserve appeared to soothe fears that it might start raising interest rates sooner than anticipated. The Federal Reserve stated......click on news to read complete article.

US markets closed lower on sanctions against Russia
(30-Jul-2014)

US markets closed lower on sanctions against RussiaThe US markets closed lower on Tuesday, as investors turned cautious after the European Union and the President Barack Obama announced a new round of sanctions against Russia for its role in Ukraine's......click on news to read complete article.

US markets closed in red on weak earnings
(26-Jul-2014)

US markets closed in red on weak earningsThe US markets closed in the red on Friday, as traders reacted negatively to the latest batch of earnings news from Amazon and Visa. Amazon closed the day down 10%, losing more than $15 billion in shareholder......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.